New Zealand markets open in 5 hours 30 minutes

NVS Jan 2024 60.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.25000.0000 (0.00%)
As of 01:02PM EDT. Market open.
Full screen
Previous close2.2500
Open2.2500
Bid1.5000
Ask3.8000
Strike60.00
Expiry date2024-01-19
Day's range2.2500 - 2.2500
Contract rangeN/A
Volume18
Open interest217
  • Motley Fool

    Could This Biosimilar Drug Candidate Be a Hit for Novartis?

    On Sept. 19, Novartis (NYSE: NVS) shared positive news with investors regarding the clinical trial results for its biosimilar drug candidate to Amgen's (NASDAQ: AMGN) osteoporosis medicine Prolia. With Prolia set to lose exclusivity in the U.S. in 2025, Novartis could be close to booking some revenue from its biosimilar drug. Let's go over the outcome of the clinical trial and the U.S. osteoporosis market to figure this out.

  • Zacks

    NVS vs. RHHBY: Which Stock Should Value Investors Buy Now?

    NVS vs. RHHBY: Which Stock Is the Better Value Option?

  • Zacks

    Is Novartis (NVS) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.